Skip directly to search
Skip directly to A to Z list
Skip directly to navigation
Skip directly to page options
Skip directly to site content
Start of Search Controls
Search Form Controls
Search The CDC
submit
CDC A-Z Index
MENU
CDC A-Z
SEARCH
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Search Form Controls
Search The CDC
submit
CDC A-Z Index
Public Health Genomics and Precision Health Knowledge Base (v9.0)
PHGKB
About
Public Health Genomics Branch
PHGKB Weekly Horizon Scan
Genomics Precision Health Scan
Advanced Molecular Detection Clips
Non-Genomics Precision Health Scan
CDC-authored Publications Scan
Specialized PHGKB
Cancer PHGKB
Diabetes PHGKB
Economic Evaluation PHGKB
Environmental Health PHGKB
Family Health History PHGKB
Health Equity PHGKB
HLBS-PopOmics
Infectious Diseases PHGKB
Implementation Science PHGKB
Neurological Disorders PHGKB
Pharmacogenomics PHGKB
Primary Immune Deficiency Diseases PHGKB
Rare Diseases PHGKB
Reproductive and Child Health PHGKB
All Databases
COVID-19 GPH (47352)
CDC/NIH Web Information Database (32181)
CDC-Authored Genomics and Precision Health Publications Database (6021)
Precision Health Database (63675)
Tier-Classified Guidelines Database (534)
Pathogen Advanced Molecular Detection Database (26775)
All of Us Reports and Publications Database (673)
Human Genome Epidemiology
Human Genome Epidemiology Literature Finder (226468)
Epigenetic Epidemiology Publications Database (22758)
Release Note
Contact Us
CDC-Authored Genomics and Precision Health Publications Database|Home|Public Health Genomics and Precision Health Knowledge Base (PHGKB)
CDC-Authored Genomics and Precision Health Publications Database
Last data update: Apr 22, 2024
. (Total: 6021 publications)
All
Cancer
Diabetes
Economic
Environmental
Equity
FHH
HLBS
ID
Implementation
ND
PGx
PI
Rare
RCH
dataset
Filtered By:
Select to fine-tune your search
Year
Journal
Next
Records 1-30 (of 33 Records)
Query Trace:
all>>Scott D Grosse[CDC Author]
Correspondence on "Cost-effectiveness of exome and genome sequencing for children with rare and undiagnosed conditions" by Lavelle et al.
Grosse SD
,
Gudgeon JM .
Genet Med 2022 24 (12) 2595-2596
Cost or price of sequencing? Implications for economic evaluations in genomic medicine.
Grosse SD
,
Gudgeon JM .
Genet Med 2021 23 (10) 1833-1835
Health and economic outcomes of newborn screening for infantile-onset Pompe disease.
Richardson JS , Kemper AR ,
Grosse SD
,
Lam WKK , Rose AM , Ahmad A , Gebremariam A , Prosser LA .
Genet Med 2020 23 (4) 758-766
Infants with Congenital Disorders Identified Through Newborn Screening - United States, 2015-2017.
Sontag MK , Yusuf C ,
Grosse SD
,
Edelman S , Miller JI , McKasson S , Kellar-Guenther Y ,
Gaffney M
,
Hinton CF
,
Cuthbert C
,
Singh S , Ojodu J ,
Shapira SK
.
MMWR Morb Mortal Wkly Rep 2020 69 (36) 1265-1268
Ensuring the Life-Span Benefits of Newborn Screening.
Kemper AR ,
Boyle CA
,
Brosco JP ,
Grosse SD
.
Pediatrics 2019 144 (6)
Using Decision Analysis to Support Newborn Screening Policy Decisions: A Case Study for Pompe Disease.
Prosser LA , Lam KK ,
Grosse SD
,
Casale M , Kemper AR .
MDM Policy Pract 2018 2018 (1)
Genomic sequencing in acutely ill infants: what will it take to demonstrate clinical value?
Grosse SD
,
Farnaes L .
Genet Med 2018 21 (2) 269-271
Is universal tumor testing for Lynch syndrome cost-effective? It depends!
Grosse SD
.
Genet Med 2018 21 (1) 252-253
Precision Medicine In Action: The Impact Of Ivacaftor On Cystic Fibrosis-Related Hospitalizations.
Feng LB ,
Grosse SD
,
Green RF , Fink AK , Sawicki GS .
Health Aff (Millwood) 2018 37 (5) 773-779
In Reference to: "Cost and Utility of Thrombophilia Testing".
Berse B , Lynch JA ,
Bowen S
,
Grosse SD
.
J Hosp Med 2017 12 (9) 783
Clinical penetrance in hereditary hemochromatosis: estimates of the cumulative incidence of severe liver disease among HFE C282Y homozygotes.
Grosse SD
,
Gurrin LC , Bertalli NA , Allen KJ .
Genet Med 2017 20 (4) 383-389
Cognitive outcomes and age of detection of severe mucopolysaccharidosis type 1.
Grosse SD
,
Lam WK ,
Wiggins LD
,
Kemper AR .
Genet Med 2017 19 (9) 975-982
The need for a next-generation public health response to rare diseases.
Valdez R
,
Grosse SD
,
Khoury MJ
.
Genet Med 2016 19 (5) 489-490
Epidemiology matters: peering inside the "black box" in economic evaluations of genetic testing.
Grosse SD
,
Khoury MJ
.
Genet Med 2016 18 (10) 963-5
Newborn screening for X-linked adrenoleukodystrophy: evidence summary and advisory committee recommendation.
Kemper AR , Brosco J , Comeau AM , Green NS ,
Grosse SD
,
Jones E , Kwon JM , Lam WK , Ojodu J , Prosser LA , Tanksley S .
Genet Med 2016 19 (1) 121-126
Cost-Effectiveness/Cost-Benefit Analysis of Newborn Screening for Severe Combined Immune Deficiency in Washington State.
Ding Y , Thompson JD , Kobrynski L , Ojodu J , Zarbalian G ,
Grosse SD
.
J Pediatr 2016 172 127-35
The health system impact of false positive newborn screening results for medium-chain acyl-CoA dehydrogenase deficiency: a cohort study.
Karaceper MD , Chakraborty P , Coyle D , Wilson K , Kronick JB , Hawken S , Davies C , Brownell M , Dodds L , Feigenbaum A , Fell DB ,
Grosse SD
,
Guttmann A , Laberge AM , Mhanni A , Miller FA , Mitchell JJ , Nakhla M , Prasad C , Rockman-Greenberg C , Sparkes R , Wilson BJ , Potter BK .
Orphanet J Rare Dis 2016 11 (1) 12
Showing Value in Newborn Screening: Challenges in Quantifying the Effectiveness and Cost-Effectiveness of Early Detection of Phenylketonuria and Cystic Fibrosis.
Grosse SD
.
Healthcare (Basel) 2015 3 (4) 1133-1157
Observed and expected frequencies of structural hemoglobin variants in newborn screening surveys in Africa and the Middle East: deviations from Hardy-Weinberg equilibrium.
Piel FB , Adamkiewicz TV , Amendah D , Williams TN , Gupta S ,
Grosse SD
.
Genet Med 2015 18 (3) 265-74
When is Genomic Testing Cost-Effective? Testing for Lynch Syndrome in Patients with Newly-Diagnosed Colorectal Cancer and Their Relatives.
Grosse SD
.
Healthcare (Basel) 2015 3 (4) 860-878
The cost-effectiveness of routine testing for Lynch syndrome in newly diagnosed patients with colorectal cancer in the United States: corrected estimates.
Grosse SD
,
Palomaki GE , Mvundura M , Hampel H .
Genet Med 2015 17 (6) 510-1
Universal state newborn screening programs can reduce health disparities.
Brosco JP ,
Grosse SD
,
Ross LF .
JAMA Pediatr 2014 169 (1) 7-8
Mortality of New York children with sickle cell disease identified through newborn screening.
Wang Y , Liu G , Caggana M , Kennedy J , Zimmerman R , Oyeku SO , Werner EM ,
Grant AM
,
Green NS ,
Grosse SD
.
Genet Med 2014 17 (6) 452-9
Criteria for fairly allocating scarce health-care resources to genetic tests: which matter most?
Rogowski WH ,
Grosse SD
,
Schmidtke J , Marckmann G .
Eur J Hum Genet 2014 22 (1) 25-31
Economic analyses of genetic tests in personalized medicine: clinical utility first, then cost utility.
Grosse SD
.
Genet Med 2013 16 (3) 225-7
The use of US health insurance data for surveillance of rare disorders: hereditary hemorrhagic telangiectasia.
Grosse SD
,
Boulet SL
,
Grant AM
,
Hulihan MM
,
Faughnan ME .
Genet Med 2013 16 (1) 33-9
Sickle cell disease incidence among newborns in New York State by maternal race/ethnicity and nativity.
Wang Y , Kennedy J , Caggana M , Zimmerman R , Thomas S , Berninger J , Harris K , Green NS , Oyeku S ,
Hulihan M
,
Grant AM
,
Grosse SD
.
Genet Med 2013 15 (3) 222-8
Modeling uncertain outcomes of genetic testing: factor V Leiden mutation and pregnant women.
Grosse SD
,
Caughey AB .
Genet Med 2013 15 (5) 335-7
Decision analysis, economic evaluation, and newborn screening: challenges and opportunities.
Prosser LA ,
Grosse SD
,
Kemper AR , Tarini BA , Perrin JM .
Genet Med 2012 14 (8) 703-712
Iron overload: what is the role of public health?
Hulihan MM
,
Sayers CA
,
Grosse SD
,
Garrison C ,
Grant AM
.
Am J Prev Med 2011 41 S422-7
File Formats Help:
How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?
Adobe PDF file
Microsoft PowerPoint file
Microsoft Word file
Microsoft Excel file
Audio/Video file
Apple Quicktime file
RealPlayer file
Text file
Zip Archive file
SAS file
ePub file
Page last reviewed:
Feb 1, 2024
Page last updated:
Apr 22, 2024
Content source:
Public Health Genomics Branch in the Division of Blood Disorders and Public Health Genomics
,
National Center on Birth Defects and Developmental Disabilities
TOP